| Clinical Study of Oncolytic Virus in Glioblastoma (NCT07145047) | Mianyang Central Hospital | 2023-11-02 |
| Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients. (NCT06061536) | Shanxi Kangbao Biological Product Co., Ltd. | 2023-11-02 |
| Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI (NCT06277674) | Guangzhou University of Traditional Chinese Medicine | 2023-11-02 |
| Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant (NCT05948540) | Global Coalition for Adaptive Research | 2023-11-02 |
| REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD (NCT05912218) | National Heart Centre Singapore | 2023-11-02 |
| Injectable Platelet-Rich Fibrin and Microneedling For Papillae Reconstruction In Esthetic Zone (NCT06021301) | Cairo University | 2023-11-01 |
| Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-2) (NCT05789823) | Capital Medical University | 2023-11-01 |
| A Study of TL-925 for the Treatment of Allergic Conjunctivitis (NCT06153342) | Telios Pharma, Inc. | 2023-11-01 |
| THE EFFECT OF VITAMIN C ON POST-ORTHODONTIC TREATMENT RELAPSE (NCT06146296) | Nourhan M.Aly | 2023-11-01 |
| Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT (NCT06075927) | Peking University People's Hospital | 2023-11-01 |
| Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate (NCT06134648) | Sanofi Pasteur, a Sanofi Company | 2023-11-01 |
| Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis (NCT05742763) | QC Kinetix LLC | 2023-11-01 |
| Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients (NCT05504642) | Universitätsklinikum Köln | 2023-11-01 |
| Oxytocin on Approach Bias and Craving (NCT03865615) | Jennifer Mitchell | 2023-11-01 |
| Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer (NCT05832892) | Shanghai Zhongshan Hospital | 2023-11-01 |
| Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations (NCT06118658) | China Medical University, China | 2023-11-01 |
| Epigallocatechin Gallate and Other Antural Compounds in HPV Infections (NCT06098456) | Centro di Ricerca Clinica Salentino | 2023-11-01 |
| Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance (NCT06118645) | China Medical University, China | 2023-11-01 |
| Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) (NCT06086288) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-11-01 |
| Empagliflozin in ESKD - A Feasibility Study (NCT05687058) | University of Mississippi Medical Center | 2023-11-01 |
| Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism (NCT05733078) | Dr Adnan Agha | 2023-11-01 |
| Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (NCT06118099) | Sanofi | 2023-11-01 |
| Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia (NCT06082934) | Xijing Hospital | 2023-11-01 |
| The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy (NCT06503276) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2023-11-01 |
| Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin (NCT06103279) | Ain Shams University | 2023-11-01 |
| Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi (NCT05126342) | AGO Research GmbH | 2023-11-01 |
| A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies (NCT06066203) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-11-01 |
| EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) (NCT06138834) | Beijing Tiantan Hospital | 2023-11-01 |
| Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC. (NCT06060704) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-01 |
| Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients (NCT06180863) | Yale University | 2023-11-01 |
| A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors (NCT06055166) | Chongqing University Cancer Hospital | 2023-11-01 |
| Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome (NCT06014138) | Guy's and St Thomas' NHS Foundation Trust | 2023-11-01 |
| Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy (NCT05714345) | Allogene Therapeutics | 2023-11-01 |
| A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis (NCT05491603) | DermBiont, Inc. | 2023-11-01 |
| Maimonides Minocycline in Stroke Study (NCT06107725) | Maimonides Medical Center | 2023-11-01 |
| Hyperpolarized 13C MRI for Cancer Immunotherapy (NCT05805358) | Chang Gung Memorial Hospital | 2023-11-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract (NCT05641272) | Inmunotek S.L. | 2023-11-01 |
| Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer (NCT06093438) | Tianjin Medical University Cancer Institute and Hospital | 2023-11-01 |
| Treat Autosomal Dominant Polycystic Kidney Disease With Oral Ketone Ester? (NCT06100133) | Universitair Ziekenhuis Brussel | 2023-11-01 |
| STOP-T1D Low-Dose (ATG) (NCT04291703) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-11-01 |
| Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONV (NCT06428084) | Universitas Padjadjaran | 2023-11-01 |
| Dronabinol for Agitation in Dementia Crossover Trial (NCT05612711) | Ralph H. Johnson VA Medical Center | 2023-11-01 |
| Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder (NCT05399498) | University of Chicago | 2023-11-01 |
| Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab (NCT06141265) | Peking University Cancer Hospital & Institute | 2023-11-01 |
| Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis (NCT06862817) | Minia University | 2023-11-01 |
| Biological Effects of Quercetin in COPD Phase II (NCT06003270) | Temple University | 2023-11-01 |
| 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder (NCT05452772) | Johns Hopkins University | 2023-11-01 |
| Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure (NCT07023016) | National Heart Institute, Egypt | 2023-11-01 |
| Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma (NCT05930665) | Sun Yat-sen University | 2023-11-01 |
| Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation (NCT06448052) | Nguyen Ton Ngoc Huynh | 2023-11-01 |
| A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases (NCT06088056) | Fudan University | 2023-11-01 |
| Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn (NCT05092685) | University College, London | 2023-11-01 |
| Effectiveness of Tofacitinib in Systemic Sclerosis (NCT06044844) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2023-11-01 |
| Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer (NCT06134193) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-11-01 |
| First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma (NCT06070740) | Peking Union Medical College Hospital | 2023-11-01 |
| Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis (NCT06047379) | Neonc Technologies, Inc. | 2023-11-01 |
| Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer (NCT05318794) | Imperial College London | 2023-11-01 |
| RCT on the Treatment of Menopausal Syndrome With Chinese Medicine (NCT06074809) | Chinese University of Hong Kong | 2023-11-01 |
| Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer (NCT04620473) | Shanghai Minimally Invasive Surgery Center | 2023-11-01 |
| SCORE Emerging Adult Cannabis Use & Stress (NCT05885542) | Medical University of South Carolina | 2023-11-01 |
| Prevention of Shivering Associated With Spinal Anesthesia (NCT06082076) | Assiut University | 2023-11-01 |
| Avatrombopag vs. Placebo for CIT in GI Malignancies (NCT05772546) | Hanny Al-Samkari, MD | 2023-11-01 |
| Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib (NCT05948462) | SCRI Development Innovations, LLC | 2023-11-01 |
| SLV213 Treatment in Ambulatory COVID-19 Patients (NCT04843787) | Kenneth Krantz, MD, PhD | 2023-11-01 |
| Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG (NCT06107374) | CellSight Technologies, Inc. | 2023-11-01 |
| Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye (NCT06517667) | University of Seville | 2023-11-01 |
| KULEA-NET: A Mobile Application for African American/Black Mothers to Promote Exclusive and Continuous Breastfeeding (NCT05985876) | Benten Technologies, Inc. | 2023-11-01 |
| Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy (NCT06099951) | Sun Yat-sen University | 2023-11-01 |
| A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer (NCT06001086) | The First Affiliated Hospital with Nanjing Medical University | 2023-11-01 |
| The Efficacy of Combination of Traditional Tibetan and Remote Ischemic Conditioning on High Altitude Polycythemia (NCT06082583) | Capital Medical University | 2023-11-01 |
| Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer (NCT05891561) | Shanghai Jiao Tong University School of Medicine | 2023-11-01 |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD (NCT05895201) | Indiana University | 2023-11-01 |
| Effect of Nicorandil in Type 2 Diabetic Obese Patients (NCT06423729) | Tanta University | 2023-11-01 |
| The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction (NCT06080802) | October University for Modern Sciences and Arts | 2023-11-01 |
| Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes (NCT05571397) | Ohio State University | 2023-11-01 |
| Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma (NCT05994235) | Weill Medical College of Cornell University | 2023-11-01 |
| Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer (NCT06154538) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-11-01 |
| Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study (NCT05356897) | Academic and Community Cancer Research United | 2023-10-31 |
| A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors (NCT05970497) | Krystal Biotech, Inc. | 2023-10-31 |
| A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs) (NCT06004336) | M.D. Anderson Cancer Center | 2023-10-31 |
| Effect of CoQ10 on the Outcome of MAFLD Patients (NCT05984745) | Ain Shams University | 2023-10-31 |
| Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial) (NCT05762211) | MaaT Pharma | 2023-10-31 |
| Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC (NCT06010888) | Fudan University | 2023-10-31 |
| Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis (NCT06224036) | Beijing Chest Hospital | 2023-10-31 |
| Test-retest Evaluation of [18F]F-AraG PET (NCT06084806) | CellSight Technologies, Inc. | 2023-10-31 |
| Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) (NCT05795244) | Yonsei University | 2023-10-31 |
| EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders (NCT06694532) | Basel khaled mohamed | 2023-10-31 |
| Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD (NCT05723588) | VA Office of Research and Development | 2023-10-31 |
| Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma (NCT05852717) | Dipenkumar Modi | 2023-10-31 |
| IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma (NCT05987332) | IDEAYA Biosciences | 2023-10-31 |
| Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR) (NCT05906953) | HuidaGene Therapeutics Co., Ltd. | 2023-10-31 |
| Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis (NCT06058299) | Global Alliance for TB Drug Development | 2023-10-31 |
| A Comprehensive Fall Prevention System for Memory Care: Final Feasibility and Randomized Controlled Study (NCT04478149) | SafelyYou | 2023-10-31 |
| Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal (NCT04939623) | University of Calgary | 2023-10-31 |
| Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents (NCT06128733) | Sanofi Pasteur, a Sanofi Company | 2023-10-31 |
| Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors (NCT06031480) | Shanghai Zhongshan Hospital | 2023-10-31 |
| Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes (NCT03929601) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-10-30 |
| A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients (NCT06087419) | Institute of Hematology & Blood Diseases Hospital, China | 2023-10-30 |
| A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT05949606) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-10-30 |
| SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer (NCT06055348) | Biocity Biopharmaceutics Co., Ltd. | 2023-10-30 |